ALPK2 identified as promising new therapeutic target for treatment of heart failure

ALPK2 identified as promising new therapeutic target for treatment of heart failure

Source: News-Medical.Net

Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that is specifically expressed in the heart.

Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that is specifically expressed in the heart. They found that the enzym… [2347 chars]

Read more